• OPEN AN ACCOUNT
Indian Indices
Sensex
74,950.14 91.15
( 0.12%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.87 0.21
(0.22%)
EUR-INR
110.00 -0.22
(-0.20%)
GBP-INR
128.18 -0.44
(-0.35%)
JPY-INR
0.61 0.00
(-0.09%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.6032787
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
43.73
84.03
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

r&er corporation ltd
Alan Scott Enterprises reports consolidated net loss of Rs 1.28 crore in the March 2026 quarter
May 27,2026
Net Loss of Alan Scott Enterprises reported to Rs 1.28 crore in the quarter ended March 2026 as against net loss of Rs 0.88 crore during the previous quarter ended March 2025. Sales declined 1.35% to Rs 8.03 crore in the quarter ended March 2026 as against Rs 8.14 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 2.98 crore in the year ended March 2026 as against net loss of Rs 1.66 crore during the previous year ended March 2025. Sales rose 19.73% to Rs 34.35 crore in the year ended March 2026 as against Rs 28.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales8.038.14 -1 34.3528.69 20
OPM %-9.468.85 -2.106.73 -
PBDT-0.940.16 PL -0.411.99 PL
PBT-2.02-0.95 -113 -4.47-1.82 -146
NP-1.28-0.88 -45 -2.98-1.66 -80